Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen

dc.contributor.authorFerreyra, Cecilia
dc.contributor.authorO’Brien, Daniel
dc.contributor.authorAlonso, Beatriz
dc.contributor.authorAl-Zomour, Abdulbasset
dc.contributor.authorFord, Nathan
dc.date.accessioned2018-07-09T12:58:15Z
dc.date.available2018-07-09T12:58:15Z
dc.date.issued2018-07-02
dc.date.updated2018-07-08T03:42:29Z
dc.description.abstractBackground: Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. Case presentation: In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%) patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic. In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network. One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%) are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning. Conclusions: This experience provides further evidence that provision of HIV treatment and emergency drug stocks can be successfully provided to most patients in both conflict-affected settings.
dc.identifier.apacitationFerreyra, C., , Alonso, B., Al-Zomour, A., & Ford, N. (2018). Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen. <i>Conflict and Health</i>, http://hdl.handle.net/11427/28282en_ZA
dc.identifier.chicagocitationFerreyra, Cecilia, , Beatriz Alonso, Abdulbasset Al-Zomour, and Nathan Ford "Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen." <i>Conflict and Health</i> (2018) http://hdl.handle.net/11427/28282en_ZA
dc.identifier.citationFerreyra, C., O’Brien, D., Alonso, B., Al-Zomour, A., & Ford, N. (2018). Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen. Conflict and Health, 12(1), 30.
dc.identifier.ris TY - Journal Article AU - Ferreyra, Cecilia AU - O’Brien, Daniel AU - Alonso, Beatriz AU - Al-Zomour, Abdulbasset AU - Ford, Nathan AB - Background: Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen. Case presentation: In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%) patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic. In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network. One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%) are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning. Conclusions: This experience provides further evidence that provision of HIV treatment and emergency drug stocks can be successfully provided to most patients in both conflict-affected settings. DA - 2018-07-02 DB - OpenUCT DP - University of Cape Town J1 - Conflict and Health LK - https://open.uct.ac.za PB - University of Cape Town PY - 2018 T1 - Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen TI - Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen UR - http://hdl.handle.net/11427/28282 ER - en_ZA
dc.identifier.urihttps://doi.org/10.1186/s13031-018-0161-1
dc.identifier.urihttp://hdl.handle.net/11427/28282
dc.identifier.vancouvercitationFerreyra C, , Alonso B, Al-Zomour A, Ford N. Provision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen. Conflict and Health. 2018; http://hdl.handle.net/11427/28282.en_ZA
dc.language.isoen
dc.publisherBioMed Central
dc.publisher.departmentDivision of Infectious Disease and HIV Meden_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rights.holderThe Author(s).
dc.sourceConflict and Health
dc.source.urihttps://conflictandhealth.biomedcentral.com/
dc.subject.otherHIV
dc.subject.otherConflict
dc.subject.otherContingency plan
dc.subject.otherEmergency response
dc.titleProvision and continuation of antiretroviral therapy during acute conflict: the experience of MSF in Central African Republic and Yemen
dc.typeJournal Article
uct.type.filetypeText
uct.type.filetypeImage
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ferreyra_2018_Article.pdf
Size:
958.84 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections